Undiagnosed chest pain sends 8-10 million Americans to Emergency Departments annually, making it the second most common complaint. Emergency physicians must rapidly identify patients whose chest pain is cardiac-related.
A new pilot study has found that a resting 90-second magnetocardiography (MCG) scan shows promise in evaluating emergency department observation unit (EDOU) chest pain patients for Acute Coronary Artery Syndrome.
The publication also indicates that CardioFlux MCG may provide additional information to support the usual clinical pathway of Stress Testing and Coronary Angiography.
Genetesis, Inc. today announced the publication of the company's initial pilot study of its CardioFlux FAC Magnetocardiograph, conducted by a team of emergency medicine physicians at a major cardiac hospital in Detroit, MI.
CardioFlux MCG is a novel medical device that can now non-invasively measure and visualize the well-studied electromagnetic function of the heart.
A CardioFlux scan is performed at rest and without the use of radiation or pharmaceuticals to record the magnetic field map generated by the electrical activity of the myocardium.
These fields have previously been shown to change with cardiac ischemia due to dysfunction of the ion channels responsible for repolarization and depolarization of the myocardium.
The study titled "A 90-second Magnetocardiogram Using a Novel Analysis System to Assess for Coronary Artery Stenosis in Emergency Department Observation Unit Chest Pain Patients" was published online by the International Journal of Cardiology Heart and Vasculature on January 8th, 2020.
Only a small minority of patients will ultimately be diagnosed with Acute Coronary Syndrome yet most are still placed in an observation unit for additional tests and monitoring.
This leads to longer hospital stays, a higher cost of care, and unnecessary downstream tests that expose patients to radiation and pharmaceuticals. CardioFlux has the potential to substantially reduce cost and wait times while improving patient experience and outcomes.
Having a non-invasive diagnostic test that can be performed rapidly with almost no patient preparation in the emergency department observation unit or possibly incorporated into the ER workflow would be a game-changer in the evaluation of ED patients presenting with chest pain"
This has a lot of potential to screen patients out [for] Coronary Artery Disease, not to mention the benefits of avoiding risks to the patient associated with radiation, adverse reactions to pharmacologic and contrast agents, as well as risks associated with hospitalization." Dr. Margarita Pena, lead author of the pilot study Related Stories
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology